Carglumic acid
Carbaglu (carglumic acid) is a small molecule pharmaceutical. Carglumic acid was first approved as Carbaglu on 2003-01-24. It is used to treat hyperammonemia in the USA. It has been approved in Europe to treat hyperammonemia, inborn errors amino acid metabolism, and propionic acidemia.
| Trade Name | Carbaglu |
|---|---|
| Common Name | Carglumic acid |
| Indication | hyperammonemia, inborn errors amino acid metabolism, propionic acidemia |
| Drug Class |
